PRICE T ROWE ASSOCIATES INC /MD/

Position in VKTX — Viking Therapeutics, Inc.

CIK 80255 BALTIMORE, MD

Position in VKTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,432,546

+$223,322 QoQ

Shares Held

105,487

+15.6% QoQ

Ownership

0.091%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. VKTX ranks #129 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	3,374,955	$2,464,560,888
2	REGN	Regeneron Pharmaceuticals, Inc.	2,177,527	$1,682,444,460
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,760,122	$785,964,877
4	INSM	INSMED Inc	3,092,807	$505,735,799
5	KYMR	Kymera Therapeutics, Inc.	6,060,847	$504,807,946
6	ALNY	Alnylam Pharmaceuticals, Inc.	1,432,748	$474,053,330
7	ASND	Ascendis Pharma A/S	1,530,345	$350,035,811
8	RVMD	Revolution Medicines, Inc.	3,232,213	$314,332,713

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,432,546	105,487	+15.6%	Shares	Sole	2026-05-15
2025-12-31	$3,209,224	91,223	+6.7%	Shares	Sole	2026-02-17
2025-09-30	$2,246,703	85,491	+9.4%	Shares	Sole	2025-11-14
2025-06-30	$2,071,743	78,179	+11.5%	Shares	Sole	2025-08-14
2025-03-31	$1,692,648	70,089	+15.4%	Shares	Sole	2025-05-14
2024-12-31	$2,443,533	60,724	-3.1%	Shares	Defined	2025-02-14
2024-09-30	$3,967,574	62,669	+5.0%	Shares	Defined	2024-11-14
2024-06-30	$3,163,106	59,670	-2.8%	Shares	Defined	2024-08-14
2024-03-31	$5,036,194	61,417	+11.2%	Shares	Defined	2024-05-15
2023-12-31	$1,027,941	55,236	+33.3%	Shares	Defined	2024-02-16
2023-09-30	$458,873	41,452	-9.0%	Shares	Defined	2023-11-14
2023-06-30	$738,592	45,564	—	Shares	Defined	2023-08-14
No filing history on record for this holder in this stock.